Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Feb;44(2):134–138. doi: 10.1136/jcp.44.2.134

Globin chain synthesis in myelodysplastic syndromes.

G Chalevelakis 1, S Karaoulis 1, A G Yalouris 1, T Economopoulos 1, N Tountas 1, S Raptis 1
PMCID: PMC496975  PMID: 1864985

Abstract

Globin chain synthesis was studied in the reticulocytes of 30 patients with various myelodysplastic syndromes (MDS) to determine the alpha:beta globin chain synthetic ratio and its probable prognostic value. The mean (SD) value of the total alpha:beta ratio was 0.82 (0.45) ranging from 0.05 to 1.73. The same ratio in 10 normal controls was 1.01 (0.04). This difference was significant. Furthermore, the alpha:beta ratios were lower than normal in 14 patients (alpha-thalassaemia-like) (group I), almost within normal limits in 11 (group II), and higher than normal in five (beta-thalassaemia-like) (group III). In each group almost all the FAB subtypes were represented. The addition of exogenous haem in several of the test samples resulted in a slight to pronounced increase in the alpha:beta ratios, particularly in group I. In 92% of the high risk cases (refractory anaemia with excess blasts (RAEB), chronic myelomonocytic leukaemia (CMML] or 87.5% of patients who finally developed acute non-lyphoid leukaemia (ANLL) low or normal alpha:beta ratios were found. No significant correlation was noticed between alpha:beta ratios and various haematological variables or survival. It is concluded that in MDS the alpha:beta ratio varied enormously across the entire population of patients, as well as within each FAB subtype, thereby restricting its prognostic value. Although haem deficiency may be implicated in some cases of MDS, why this should be remains unclear.

Full text

PDF
134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbondanzo S. L., Anagnou N. P., Sacher R. A. Myelodysplastic syndrome with acquired hemoglobin H disease. Evolution through megakaryoblastic transformation into myelofibrosis. Am J Clin Pathol. 1988 Mar;89(3):401–406. doi: 10.1093/ajcp/89.3.401. [DOI] [PubMed] [Google Scholar]
  2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 Jun;51(2):189–199. [PubMed] [Google Scholar]
  3. Beutler E., West C., Blume K. G. The removal of leukocytes and platelets from whole blood. J Lab Clin Med. 1976 Aug;88(2):328–333. [PubMed] [Google Scholar]
  4. Cetto G. L., Vettore L., De Matteis M. C., Piga A., Perona G. Erythrocyte cation content, globin chain synthesis and glucose metabolism in dysmyelopoietic syndromes. Acta Haematol. 1982;68(2):124–130. doi: 10.1159/000206963. [DOI] [PubMed] [Google Scholar]
  5. Chalevelakis G., Clegg J. B., Weatherall D. J. Globin synthesis in normal human bone marrow. Br J Haematol. 1976 Dec;34(4):535–557. doi: 10.1111/j.1365-2141.1976.tb03600.x. [DOI] [PubMed] [Google Scholar]
  6. Chalevelakis G., Clegg J. B., Weatherall D. J. Imbalanced globin chain synthesis in heterozygous beta-thalassemic bone marrow. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3853–3857. doi: 10.1073/pnas.72.10.3853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chalevelakis G., Yalouris A. G., Lyberatos C., Economopoulos T., Anastasiou C., Hatziioannou J., Raptis S. Effect of isoniazid, a haem inhibitor, on globin chain synthesis in reticulocytes from non-thalassaemic and beta thalassaemic subjects. J Clin Pathol. 1989 Sep;42(9):977–981. doi: 10.1136/jcp.42.9.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clegg J. B., Weatherall D. J. Haemoglobin synthesis during erythroid maturation in -thalassaemia. Nat New Biol. 1972 Dec 6;240(101):190–192. doi: 10.1038/newbio240190a0. [DOI] [PubMed] [Google Scholar]
  9. Franco R. S., Hogg J. W., Martelo O. J. The effect of INH-inhibited heme synthesis on globin synthesis. J Lab Clin Med. 1979 Apr;93(4):679–686. [PubMed] [Google Scholar]
  10. Galton D. A. The myelodysplastic syndromes. Part I. What are they? Part II. Classification. Scand J Haematol Suppl. 1986;45:11–20. [PubMed] [Google Scholar]
  11. Hamblin T. J., Oscier D. G. The myelodysplastic syndrome--a practical guide. Hematol Oncol. 1987 Jan-Mar;5(1):19–34. doi: 10.1002/hon.2900050104. [DOI] [PubMed] [Google Scholar]
  12. Legon S., Jackson R. J., Hunt T. Control of protein synthesis in reticulocyte lysates by haemin. Nat New Biol. 1973 Jan 31;241(109):150–152. doi: 10.1038/newbio241150a0. [DOI] [PubMed] [Google Scholar]
  13. Levine A. M., Taylor C. R., Schneider D. R., Koehler S. C., Forman S. J., Lichtenstein A., Lukes R. J., Feinstein D. I. Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features. Blood. 1981 Jul;58(1):52–61. [PubMed] [Google Scholar]
  14. Lofters W. S., Ali M. A., Pineo G. F. Preleukaemia and reticulocytosis: a case report with in vitro evidence for abnormal reticulocyte maturation. Scand J Haematol. 1978 May;20(5):417–422. doi: 10.1111/j.1600-0609.1978.tb02477.x. [DOI] [PubMed] [Google Scholar]
  15. Maxwell C. R., Rabinovitz M. Evidence for an inhibitor in the control of globin synthesis by hemin in a reticulocyte lysate. Biochem Biophys Res Commun. 1969 Apr 10;35(1):79–85. doi: 10.1016/0006-291x(69)90485-9. [DOI] [PubMed] [Google Scholar]
  16. Pagnier J., Labie D. Abnormal hemoglobin synthesis in some leukemic patients. Biochimie. 1975;57(1):71–76. doi: 10.1016/s0300-9084(75)80111-8. [DOI] [PubMed] [Google Scholar]
  17. Pagnier J., Lopez M., Mathiot C., Habibi B., Zamet P., Varet B., Labie D. An unusual case of leukemia with high fetal hemoglobin: demonstration of abnormal hemoglobin synthesis localized in a red cell clone. Blood. 1977 Aug;50(2):249–258. [PubMed] [Google Scholar]
  18. Peters R. E., May A., Jacobs A. Globin chain synthesis ratios in sideroblastic anaemia. Br J Haematol. 1983 Feb;53(2):201–209. doi: 10.1111/j.1365-2141.1983.tb02012.x. [DOI] [PubMed] [Google Scholar]
  19. Peters R. E., May A., Jacobs A. Increased alpha:non-alpha globin chain synthesis ratios in myelodysplastic syndromes and myeloid leukaemia. J Clin Pathol. 1986 Nov;39(11):1233–1235. doi: 10.1136/jcp.39.11.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Raskind W. H., Tirumali N., Jacobson R., Singer J., Fialkow P. J. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood. 1984 Jun;63(6):1318–1323. [PubMed] [Google Scholar]
  21. Sheffer R., Cividalli G., Zaharan Y., Tamari H., Okon E. Disturbed patterns of globin chain synthesis in childhood monosomy 7 myeloproliferative syndrome. Br J Haematol. 1988 Mar;68(3):357–362. doi: 10.1111/j.1365-2141.1988.tb04214.x. [DOI] [PubMed] [Google Scholar]
  22. Veer A., Kosciolek B. A., Bauman A. W., Rowley P. T. Acquired hemoglobin H disease in idiopathic myelofibrosis. Am J Hematol. 1979;6(3):199–206. doi: 10.1002/ajh.2830060304. [DOI] [PubMed] [Google Scholar]
  23. Weatherall D. J., Clegg J. B., Na-Nakorn S., Wasi P. The pattern of disordered haemoglobin synthesis in homozygous and heterozygous beta-thalassaemia. Br J Haematol. 1969 Mar;16(3):251–267. doi: 10.1111/j.1365-2141.1969.tb00400.x. [DOI] [PubMed] [Google Scholar]
  24. Weatherall D. J., Old J., Longley J., Wood W. G., Clegg J. B., Pollock A., Lewis M. J. Acquired haemoglobin H disease in leukemia: pathophysiology and molecular basis. Br J Haematol. 1978 Mar;38(3):305–322. doi: 10.1111/j.1365-2141.1978.tb01049.x. [DOI] [PubMed] [Google Scholar]
  25. White J. M., Ali M. A. Globin synthesis in sideroblastic anaemia. II. The effect of pyridoxine, -aminolaevulinic acid and haem, in vitro. Br J Haematol. 1973 Apr;24(4):481–489. doi: 10.1111/j.1365-2141.1973.tb01674.x. [DOI] [PubMed] [Google Scholar]
  26. White J. M., Brain M. C., Ali M. A. Globin synthesis in sideroblastic anaemia. I. Alpha and beta peptide chain synthesis. Br J Haematol. 1971 Mar;20(3):263–275. doi: 10.1111/j.1365-2141.1971.tb07037.x. [DOI] [PubMed] [Google Scholar]
  27. Worsley A., Oscier D. G., Stevens J., Darlow S., Figes A., Mufti G. J., Hamblin T. J. Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol. 1988 Jan;68(1):17–21. doi: 10.1111/j.1365-2141.1988.tb04173.x. [DOI] [PubMed] [Google Scholar]
  28. Yoo D., Schechter G. P., Amigable A. N., Nienhuis A. W. Myeloproliferative syndrome with sideroblastic anemia and acquired hemoglobin H disease. Cancer. 1980 Jan 1;45(1):78–83. doi: 10.1002/1097-0142(19800101)45:1<78::aid-cncr2820450114>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES